This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Regeneron Pharmaceuticals, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Innovations by Stacy Wasinger in Biopharmaceuticals
Introduction
Stacy Wasinger is an accomplished inventor based in Hopewell Junction, NY (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the area of reducing particle formation in drug products. Her innovative work has the potential to enhance the efficacy and safety of biopharmaceutical compositions.
Latest Patents
Stacy Wasinger holds 1 patent for her invention titled "Methods of reducing particle formation and compositions formed thereby." This patent describes biopharmaceutical compositions and drug products that exhibit reduced amounts of subvisible particle formation. The compositions include a protein and a surfactant or stabilizer, which contains high percentage amounts (e.g., at least 97%) of a long-chain fatty acid ester. Additionally, the patent outlines methods for preparing and storing these compositions and drug products.
Career Highlights
Stacy is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to advance her research and development efforts in biopharmaceuticals. Her work at Regeneron has positioned her as a key player in the industry, contributing to the development of innovative drug products.
Collaborations
Stacy collaborates with talented colleagues, including Mayank Patel and Danya Spritzer. These partnerships enhance her research efforts and contribute to the success of their projects.
Conclusion
Stacy Wasinger's contributions to biopharmaceuticals through her innovative patent demonstrate her commitment to improving drug formulations. Her work not only addresses critical challenges in the industry but also paves the way for future advancements in biopharmaceutical compositions.